Live Breaking News & Updates on Drug controller general of india

Stay informed with the latest breaking news from Drug controller general of india on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Drug controller general of india and stay connected to the pulse of your community

Drug Controller General of India: New initiative by Drug Controller General of India to boost ease of doing business

The Drug Controller General of India (DCGI) plans to hold walk-in meetings with stakeholders to improve the ease of doing business in India. Starting on February 20, these meetings will take place every Tuesday and Thursday at the CDSCO Headquarters. The DCGI, responsible for drug approval, clinical trials, drug standards, imported drug quality control, and State Drug Control Organization coordination, aims to hear complaints, grievances, and suggestions for swift resolution.

Business-news , Breaking-news , Latest-news-updates , Economic-times , Economic-times-news-app , Daily-market-updates , Live-business , Economic-times-prime , Drug-controller-general-of-india , Dcgi , Walk-in-meetings

Newsmaker | 'Upgrade Quality or Risk Shutdowns': How India's New DCGI is Rebuilding 'Pharmacy of the World'

In February, India appointed Raghuvanshi, the first DCGI from the corporate world who boasted of stints at Ranbaxy and Dr. Reddy’s among others

United-states , Uzbekistan , Marshall-islands , Gambia , Matai , India-general- , India , Sri-lanka , Micronesia , Rajeev-singh-raghuvanshi , Viranchi-shah , Indian-pharma

Who is responsible at drugmakers? Regulator wants to find out

India’s drug regulator plans to order all drug companies to name a ‘responsible person’ who will be accountable for their day-to-day affairs

Gambia , India , Uzbekistan , Rajeev-singh-raghuvanshi , Cosmetics-act , Drug-regulator , Responsible-person , Drug-controller-general-of-india , Dcgi , Drug-licences , Drugs-and-cosmetics-act

Over 50 cough syrup manufacturers in India fail quality tests: Government report

India Business News: A government report reveals that more than 50 companies in India manufacturing cough syrups have failed quality tests. Out of 2,104 test reports, 128

India , Gambia , Ghaziabad , Uttar-pradesh , Regional-drugs-testing-laboratory-in-chandigarh , Central-drugs-standard-control-organisation , Maiden-pharmaceuticals , Indian-pharmacopoeia-commission , Maiden-pharmaceuticals-ltd , World-health-organization , Regional-drugs-testing-laboratory

Rule regulating Ayush ads set to go, but amendments to fill void in limbo for a year

The Drug Controller General of India (DCGI) has suggested that a rule regulating the advertisement of ayush drugs should only be withdrawn after amend

India , Ayurvedic-siddha , Drug-controller-general , Magic-remedies-act , Unani-drugs-technical-advisory-board , Magic-remedies , Objectionable-advertisements , Cosmetics-rules , Rti-response , Health-ministry , Drug-controller-general-of-india

novo nordisk: Novo Nordisk gets approval to carry out clinical trials on weekly insulin

Novo Nordisk has received approval from the Drug Controller General of India to conduct phase-III studies for its new weekly insulin injection, IcoSema, in India. IcoSema is a combination of insulin and Semaglutide and is meant to control blood sugar levels in people with type-two diabetes. The proposed weekly insulin shot could be a game changer as it would decrease the discomfort of daily injections and may be as effective as regular insulin.

Denmark , India , Danish , Anoop-misra , Ozempic-semaglutide , Centre-of-excellence , Novo-nordisk , Drug-administration , Drug-controller-general , Metabolic-diseases , Icosema , Semaglutide

dcgi: After crackdown on spurious medicines, India's drug regulator collating data of pharma plants

The companies have also been asked to share information on international approvals obtained from the European Union, US Food and Drug Administration, Japan's Pharmaceuticals and Medical Devices Agency, Brazilian Health Regulatory Agency (Anvisa), among other regulatory bodies abroad.

India , Japan , Gambia , New-delhi , Delhi , Kozhikode , Kerala , Devices-agency , Healthcare-management-analytics-programme , Brazilian-health-regulatory-agency-anvisa , European-union

digene: Digene users, take note! Health regulator has issued an important advisory for you

The Drug Controller General of India has issued a cautionary advisory to doctors and healthcare professionals regarding the discontinuation of Digene gel in the event of adverse drug reactions. This follows a complaint received by the DCGI about a batch of Digene gel produced by Abbott India in Goa, which had unusual characteristics.

Kozhikode , Kerala , India , Healthcare-management-analytics-programme , Indian-school-of-business , Central-drug-standards-control-organisation , Offering-college , Drug-controller-general , Abbott-india , Healthcare-expertise , Cosmetics-act

Abbott India recalls antacid Digene Gel after DCGI advisory

State drugs controllers have been advised to keep strict vigil on the movement, sale and distribution and stock of the said products in the market, draw samples if the product is lying in the market, and initiate necessary action

India , Digene-gel , Cosmetic-act , Abbott , Abbott-india , Drugmaker , Recall , Digene-recall , Dcgi , Drug-controller-general-of-india , Advisory

Abbott India recalls antacid Digene Gel, DCGI issues advisory

State drugs controllers have been advised to keep strict vigil on the movement, sale and distribution and stock of the said products in the market, draw samples if the product is lying in the market, and initiate necessary action

India , Digene-gel , Cosmetic-act , Abbott , Abbott-india , Drugmaker , Recall , Digene-recall , Dcgi , Drug-controller-general-of-india , Advisory